Rudi Müller-Walz

Title: Rudi Müller-Walz: Innovator in Dry Powder Inhalation Technology

Introduction

Rudi Müller-Walz is a notable inventor based in Schopfheim, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of dry powder for inhalation. His innovative approach aims to enhance the moisture resistance and storage stability of inhalation formulations.

Latest Patents

Rudi Müller-Walz holds a patent for a dry powder formulation designed for inhalation. The primary objective of this invention is to improve the moisture resistance of dry powder formulations that contain a pharmaceutically ineffective carrier of non-inhalable particle size, along with a finely divided pharmaceutically active compound of inhalable particle size. The formulation incorporates magnesium stearate to achieve these goals. One of the standout features of this dry powder is its ability to maintain a high fine particle dosage or fine particle fraction, even under extreme temperature and humidity conditions. He has 1 patent to his name.

Career Highlights

Rudi Müller-Walz is associated with Jagotec AG, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a key player in the development of advanced inhalation therapies.

Collaborations

Rudi collaborates with Manfred Keller, contributing to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Rudi Müller-Walz's work in dry powder inhalation technology exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions are paving the way for improved inhalation therapies that can withstand challenging environmental conditions.